47 /100
MEDIUM RISK
Score updated Jul 14, 2026

QNRX — Quoin Pharmaceuticals, Ltd. Dilution Risk Tracker

Track QNRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track QNRX — Get alerts when the score changes →

As of July 14, 2026, Quoin Pharmaceuticals, Ltd. (QNRX) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. Quoin Pharmaceuticals, Ltd. has a market capitalization of $10.16M, 3.35B shares outstanding, 21 institutional holders tracked. Key dilution vectors include approximately 16 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
0
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for QNRX.
🔔 Track QNRX — Get forecast alerts →

💹 Market Data

Market Cap$10.16M
Shares Outstanding3.35B
FloatN/A
Cash$14.04M
Debt$2.17M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 40.6% shares (2026Q1 vs prior)
21 institutional holders · 1.27M shares
#1 Ikarian Capital, LLC 211.5K shares
#2 Dauntless Investment Group, LLC 196.6K shares
#3 Woodline Partners LP 159.2K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest261.9K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Oct 14, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Mar 31, 2026
4 INSIDER TRANSACTION Feb 06, 2026
4 INSIDER TRANSACTION Feb 06, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for QNRX Shareholders

Quoin Pharmaceuticals, Ltd. (QNRX) has a DilutionScore of 47/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

Cash runway is a key watch item: QNRX has approximately 16 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for QNRX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for QNRX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track QNRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking QNRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT ACH AHRT ALOT AMPH

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for QNRX
📊 QNRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 QNRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.